Skip to main content
Clinical Trials/NCT00855673
NCT00855673CompletedPhase 4

Intermittent Mechanical Compression For Peripheral Arterial Disease

Hospital Universitario Getafe0 sites30 target enrollmentStarted: January 2001Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
30
Primary Endpoint
exercise tolerance

Study Overview

Brief Summary

The study tests the use of a portable mechanical compression device (FM220, Flowmedic, USA) for the treatment of claudication and peripheral arterial disease.

Major endpoints are improved exercise tolerance and relevant blood pressure ratios

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
50 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • stable claudication with an absolute claudication distance >40 meters but <300
  • resting ABI in the affected limb <0.8

Exclusion Criteria

  • presence of diabetes

Arms & Interventions

Active

Experimental

Active group receiving intermittent compression

Intervention: Intermittent Mechanical Compression (Device)

Control

Active Comparator

Standard Medical Treatment

Intervention: Control (Drug)

Outcomes

Primary Outcomes

exercise tolerance

Time Frame: 3 months

Secondary Outcomes

  • ankle-brachial index(3 months)

Investigators

Sponsor
Hospital Universitario Getafe
Sponsor Class
Other

Similar Trials

Intermittent Mechanical Compression For... | Clinical Trial